Clinical trial
Efficacy of Maintenance Therapy With Rituximab After Induction Chemotherapy (R-CHOP vs. R-FC) for Elderly Patients With Mantle Cell Lymphoma Not Suitable for Autologous Stem Cell Transplantation
NCT00209209 is registered in ClinicalTrials.gov with European Mantle Cell Lymphoma Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Maintenance Therapy With Rituximab After Induction Chemotherapy (R-CHOP vs. R-FC) for Elderly Patients With Mantle Cell Lymphoma Not Suitable for Autologous Stem Cell Transplantation
- Lead sponsor
- European Mantle Cell Lymphoma Network
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 14, 2004
- Completion date
- December 31, 2018
- Enrollment
- 570 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.